For example, in IDH-mutant tumours, the aberrant metabolite 2-hydroxyglutarate (2-HG), produced in the tricarboxylic acid cycle, can inhibit TET-mediated DNA demethylation, thus causing genome hypermethylation (Xu et al., 2011). Here, IDH1 is linked to neoplasm.